Wang Yeming, Wei Dong, Wang Zhenxing, Zheng Mingfeng, Chen Jingyu
Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Thoracic Transplant, Wuxi, China.
Exp Clin Transplant. 2012 Oct;10(5):519-21. doi: 10.6002/ect.2011.0186. Epub 2012 Jul 3.
Because of the potential risk of recurrence and dissemination, lung carcinoma is rarely considered an indication for lung transplant, but as the technique has improved, novel end-stage pulmonary diseases can be treated successfully. Experience in lung transplant for patients with lung carcinoma has shown that select patients may benefit from this therapy. In this report, we examine the case of a bilateral lung transplant in a young man with bilateral bronchioloalveolar carcinoma. This report suggests that bilateral lung transplant might be an efficient therapeutic option for select patients with lung carcinoma.
由于存在复发和播散的潜在风险，肺癌很少被视为肺移植的适应证，但随着技术的进步，新型终末期肺部疾病能够得到成功治疗。肺癌患者肺移植的经验表明，部分患者可能从这种治疗中获益。在本报告中，我们探讨了一名患有双侧细支气管肺泡癌的年轻男性接受双侧肺移植的病例。本报告提示，双侧肺移植可能是部分肺癌患者的一种有效治疗选择。
